Status:

UNKNOWN

Evaluation of Abdominal Tissue Oxygenation in Premature Infants Using Near Infrared Spectroscopy

Lead Sponsor:

Brigham and Women's Hospital

Conditions:

Infant, Premature, Diseases

Hypoxia

Eligibility:

All Genders

Up to 3 years

Brief Summary

There is an increasing incidence of Necrotizing Enterocolitis (NEC) affecting the premature infant population, principally those with associated risk like extreme prematurity, extreme low birth weight...

Detailed Description

We will include, 10 premature infants from 32 to 36 weeks of post menstrual age, within the first week of life, that are clinically stable without diagnosis of Congenital Heart Disease, Necrotizing En...

Eligibility Criteria

Inclusion

  • Preterm infant (32 to 36 weeks of postmenstrual age)
  • Neonatal intensive care unit (NICU) patient
  • Stable clinical condition (i.e. Vital signs, Hemodynamics)
  • Age less than 6 weeks of life

Exclusion

  • Congenital Heart Disease
  • Necrotizing enterocolitis prior to inclusion
  • Non stable clinical condition
  • Blood transfused less than three days prior to inclusion
  • Abdominal injuries (i.e. Omphalocele, Gastroschisis, Skin irritation) that impedes placement of the optodes

Key Trial Info

Start Date :

February 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 1 2016

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT01855347

Start Date

February 1 2016

End Date

July 1 2016

Last Update

August 25 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham and Women's Hospital Newborn Medicine Department

Boston, Massachusetts, United States, 02215